European Medicines Agency Unveils New HMA-EMA Catalogues

Launch Announcement

The European Medicines Agency has unveiled the highly anticipated new HMA-EMA catalogues of real-world data sources and studies, marking a significant milestone in healthcare regulation and innovation.

Invaluable Resource

Building on the foundation of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP), these catalogues serve as an invaluable resource for stakeholders across the healthcare landscape. Whether you’re a healthcare professional, researcher, regulator, or industry leader, these catalogues provide essential information for utilising data in medicines regulation.

Key Benefits

By centralizing real-world data sources and studies, the catalogues streamline access to critical information, facilitating evidence-based decision-making and fostering transparency within the regulatory process. This initiative underscores the EMA’s commitment to promoting patient safety, driving innovation, and enhancing regulatory efficiency.

Explore Further

Visit the EMA’s official website to access the newly launched catalogues and discover the wealth of resources available through the ENCePP platform.

Access Catalogues

ENCePP Website

Stay tuned for more updates and insights as we continue to navigate the evolving landscape of healthcare regulation and innovation.

Scroll to Top